Follow the latest coverage, related explainers and connected technology stories.
UK-based Sava Technologies raised $36 million in a Series B round led by Ascensia Diabetes Care, which also received exclusive rights to market and distribute the sensor in Europe. The company aims to launch a wearable sensor after conducting a pivotal trial and seek CE marking within the next two years.